국가 R&D 과제의 생명윤리 관리체계 구축에 대한 고찰
Oversight on the Bioethical Compliance of National R&D Projects or Research Personnel
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Oversight on the bioethical compliance of national R&D projects or research personnel is currently conducted exclusively by IRB (Institutional Review Board) within the relevant research institute. Considering current state of affairs in Korea, there is an imperative to establish a national oversight system for bioethical compliance, conduct comprehensive oversight on bioethical compliance of national R&D projects, and enhance subject protection system. Methods: We examined opinions from researchers and IRB personnels regarding ethical oversight system on R&D projects. Additionally, we looked at IRB assessment by KAIRB (Korea Association of Institutional Review Board) in order to identify status and problems with current IRB system in Korea. Assessment was also done for four other countries (US, UK, Germany, Singapore) through in-person visits as well as surveys in writing for a total of 6 months (2012.12.1~2013.5.31). The research comprised of two aspects: system management and R&D project audit. Based on this, we examined current status and problems of the existing system in Korea and made recommendations for improvement. Results: Regulatory objectives and backgrounds of biomedical researches are different from each country due to different characteristics of bioethical oversight system. This shows that each country sets up its own regulations and procedures to fit each situation. Bioethical compliance oversight system greatly varied between the countries. From this study, it can be seen that improvement of existing procedures and oversight system or establishment of new ones are essential in Korea. Conclusion: In terms of system management, a dedicated government organization need to be established for bioethical compliance, subject protection, IRB inspection, training, evaluation, and certification of systems, and also support for IRB e-system. Regarding R&D project oversight, it is essential to confirm IRB review results before start of a research, to conduct a review on ethical aspects of research plans, and to carry out continued oversight on bioethical compliance through interim reports.
Abstract
Background: Oversight on the bioethical compliance of national R&D projects or research personnel is currently conducted exclusively by IRB (Institutional Review Board) within the relevant research institute. Considering current state of affairs in Korea, there is an imperative to establish a national oversight system for bioethical compliance, conduct comprehensive oversight on bioethical compliance of national R&D projects, and enhance subject protection system. Methods: We examined opinions from researchers and IRB personnels regarding ethical oversight system on R&D projects. Additionally, we looked at IRB assessment by KAIRB (Korea Association of Institutional Review Board) in order to identify status and problems with current IRB system in Korea. Assessment was also done for four other countries (US, UK, Germany, Singapore) through in-person visits as well as surveys in writing for a total of 6 months (2012.12.1~2013.5.31). The research comprised of two aspects: system management and R&D project audit. Based on this, we examined current status and problems of the existing system in Korea and made recommendations for improvement. Results: Regulatory objectives and backgrounds of biomedical researches are different from each country due to different characteristics of bioethical oversight system. This shows that each country sets up its own regulations and procedures to fit each situation. Bioethical compliance oversight system greatly varied between the countries. From this study, it can be seen that improvement of existing procedures and oversight system or establishment of new ones are essential in Korea. Conclusion: In terms of system management, a dedicated government organization need to be established for bioethical compliance, subject protection, IRB inspection, training, evaluation, and certification of systems, and also support for IRB e-system. Regarding R&D project oversight, it is essential to confirm IRB review results before start of a research, to conduct a review on ethical aspects of research plans, and to carry out continued oversight on bioethical compliance through interim reports.
참고문헌 (28)
- The 2012 report of National R&D projects research and analysis, "Lee SY", Ministry of Science, ICT and Future planning. Korea institute of S&T evaluation and planning, ~ (2013)
- "Health-related technologies made of 75% in developed contries"[URL]
- "The 3rd science and technology basic plan"[URL]
- 서이종, "미국 터스키기 매독연구의 생명윤리 논란과 그 영향", 사회와역사(구 한국사회사학회논문집), (83), pp.187~221 (2009), 한국사회사학회
- "Installation and function of Institutional review Board. Bioethics and Safety Act. Article 10 Section 2. Revision Date March 23. 2013", ~ (2013)
- Lee C, "Severance hospital AAHRPP full-reaccrediation", Yonsei university health system news. 706. October 7. 2013, ~ (2013)
- "Kyunghee university hospital acquired clinical research AAHRPP"[URL]
- Kim OJ, "Seoul national university hospital acquired AAHRPP accreditation", Seoul National University Hospital Center for Human Research Protection. Newsletter. 2, ~ (2012)
- "Accessed July 18, 2014"[URL]
- "The selection of research and development projects. Regulations concerning the management of national research and development projects. Article 7 Section 2. Revision Date September 26. 2013", ~ (2013)
- "Such as the prohibition of research misconduct. Regulations concerning the management of national research and development projects. Article 7 Section 30. Revision Date March 23. 2013", ~ (2013)
- Jo GH, "Measures for ensuring international standards of bioethics", Korea national institute for bioethics policy, ~ (2012)
- Choi BI, "Life science research ethics", GCO Science & Technology, ~ (2009)
- 강영희, "국가연구개발과제 생명의학윤리 감독체계에 대한 인식조사 및 제언", 한국임상약학회지, 24(2), pp.135~143 (2014), 한국임상약학회
- "Federal Policy for the Protection of Human Subjects (Common Rule)"[URL]
- "Code of Federal Regulations"[URL]
- "Food & Drug Administration"[URL]
- Federal register, "Authenticated U.S. Government information", GPO. 2013;78(38), ~ (2013)
- "About OHRP"[URL]
- "The health and care system in UK"[URL]
- Study for detailed management plan of IRB, "Kim SD", 4~24 (2012)
- "Basic law for the federal republic of Germany. Article 5"[URL]
- Organization and operating conditions of DFG(Deutsche Forschungsgemeinschaft:German research association), "Park JH", Science & Technology policy institute, ~ (2002)
- "Basic law for the federal republic of Germany. Article 1,2"[URL]
- "Role of MOH"[URL]
- "NIH grants & funding"[URL]
- "Electronic research administration(eRA) services"[URL]
- "REC; annual progress report forms"[URL]